SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-134372
Filing Date
2021-11-04
Accepted
2021-11-04 16:08:36
Documents
12
Period of Report
2021-11-01
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131644d1_8k.htm   iXBRL 8-K 22085
  Complete submission text file 0001104659-21-134372.txt   196616

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxi-20211101.xsd EX-101.SCH 3189
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20211101_lab.xml EX-101.LAB 34594
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20211101_pre.xml EX-101.PRE 22713
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2131644d1_8k_htm.xml XML 3699
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 211379971
SIC: 2834 Pharmaceutical Preparations